- Home
- Publications
- Publication Search
- Publication Details
Title
Immunosuppressive Drugs in Liver Transplant: An Insight
Authors
Keywords
-
Journal
Journal of Clinical and Experimental Hepatology
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-06-22
DOI
10.1016/j.jceh.2022.06.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early everolimus‐facilitated reduced tacrolimus in liver transplantation: Results from the randomized HEPHAISTOS trial
- (2021) Björn Nashan et al. LIVER TRANSPLANTATION
- Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients
- (2020) Sung Gyu Lee et al. TRANSPLANTATION
- Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group
- (2020) Umberto Cillo et al. Hepatology International
- Time to Conversion to an Everolimus‐Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER Registry
- (2020) Faouzi Saliba et al. LIVER TRANSPLANTATION
- ABO-Incompatible Adult Living Donor Liver Transplantation in the Era of Rituximab: A Systematic Review and Meta-Analysis
- (2019) Dipesh Kumar Yadav et al. Gastroenterology Research and Practice
- No Gains in Long-Term Survival After Liver Transplantation Over the Past Three Decades
- (2018) Abbas Rana et al. ANNALS OF SURGERY
- International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients
- (2018) Michael Charlton et al. TRANSPLANTATION
- Belatacept in Solid Organ Transplant
- (2018) Caroline P. Perez et al. TRANSPLANTATION
- Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation
- (2017) Tiffany CL Wong et al. EXPERT OPINION ON EMERGING DRUGS
- Use of Everolimus in Liver Transplantation
- (2017) Paolo De Simone et al. TRANSPLANTATION
- 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection
- (2016) A. J. Demetris et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Eculizumab Therapy for Chronic Antibody-Mediated Injury in Kidney Transplant Recipients: A Pilot Randomized Controlled Trial
- (2016) S. Kulkarni et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Long-term follow-up of five yr shows superior renal function with everolimus plus early calcineurin inhibitor withdrawal in the PROTECT randomized liver transplantation study
- (2016) Martina Sterneck et al. CLINICAL TRANSPLANTATION
- Prevention and treatment of liver allograft antibody-mediated rejection and the role of the ‘two-hit hypothesis’
- (2016) Peter T.W. Kim et al. Current Opinion in Organ Transplantation
- Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma
- (2016) Elizabeth L. Yanik et al. LIVER TRANSPLANTATION
- Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma
- (2016) Edward K. Geissler et al. TRANSPLANTATION
- Lack of agreement for defining ‘clinical suspicion of rejection’ in liver transplantation: a model to select candidates for liver biopsy
- (2015) Manuel Rodríguez-Perálvarez et al. TRANSPLANT INTERNATIONAL
- Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus
- (2015) Lutz Fischer et al. TRANSPLANTATION
- Everolimus and Early Calcineurin Inhibitor Withdrawal: 3-Year Results From a Randomized Trial in Liver Transplantation
- (2014) M. Sterneck et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Is Minimal, [Almost] Steroid-Free Immunosuppression a Safe Approach in Adult Liver Transplantation? Long-term Outcome of a Prospective, Double Blind, Placebo-Controlled, Randomized, Investigator-Driven Study
- (2014) Jan P. Lerut et al. ANNALS OF SURGERY
- Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update
- (2014) Christine E. Staatz et al. ARCHIVES OF TOXICOLOGY
- Focus on mTOR inhibitors and tacrolimus in renal transplantation: Pharmacokinetics, exposure–response relationships, and clinical outcomes
- (2014) Fuad Shihab et al. TRANSPLANT IMMUNOLOGY
- Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review
- (2014) Evangelos Cholongitas et al. TRANSPLANT INTERNATIONAL
- Calcineurin Inhibitor Nephrotoxicity: A Review and Perspective of the Evidence
- (2013) Naim Issa et al. AMERICAN JOURNAL OF NEPHROLOGY
- Renal Function at Two Years in Liver Transplant Patients Receiving Everolimus: Results of a Randomized, Multicenter Study
- (2013) F. Saliba et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Completely steroid-free immunosuppression in liver transplantation: a randomized study
- (2013) Carlo B. Ramirez et al. CLINICAL TRANSPLANTATION
- Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss
- (2013) Jacqueline G. O'Leary et al. LIVER TRANSPLANTATION
- Induction immunosuppression in liver transplantation: a review
- (2013) Alexandra P. Turner et al. TRANSPLANT INTERNATIONAL
- Late Acute Liver Allograft Rejection; A Study of Its Natural History and Graft Survival in the Current Era
- (2013) Prem H. Thurairajah et al. TRANSPLANTATION
- Bortezomib for Acute Antibody-Mediated Rejection in Liver Transplantation
- (2012) F. Paterno et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Sirolimus Conversion Regimen Versus Continued Calcineurin Inhibitors in Liver Allograft Recipients: A Randomized Trial
- (2012) M. F. Abdelmalek et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation-PROTECT
- (2012) L. Fischer et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Tacrolimus Trough Levels, Rejection and Renal Impairment in Liver Transplantation: A Systematic Review and Meta-Analysis
- (2012) M. Rodríguez-Perálvarez et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Everolimus With Reduced Tacrolimus Improves Renal Function inDe NovoLiver Transplant Recipients: A Randomized Controlled Trial
- (2012) P. De Simone et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Risk of de novo cancers after transplantation: Results from a cohort of 7217 kidney transplant recipients, Italy 1997–2009
- (2012) Pierluca Piselli et al. EUROPEAN JOURNAL OF CANCER
- Long-term Medical Management of the Liver Transplant Recipient: What the Primary Care Physician Needs to Know
- (2012) Siddharth Singh et al. MAYO CLINIC PROCEEDINGS
- Bortezomib Is Effective to Treat Acute Humoral Rejection After Liver Transplantation
- (2012) C.-F. Lee et al. TRANSPLANTATION PROCEEDINGS
- Mycophenolate mofetil monotherapy in liver transplant recipients
- (2011) Michael Kriss et al. CLINICAL TRANSPLANTATION
- Present state of immunosuppressive therapy in liver transplant recipients
- (2011) Russell H. Wiesner et al. LIVER TRANSPLANTATION
- Outcome of induction immunosuppression for liver transplantation comparing anti-thymocyte globulin, daclizumab, and corticosteroid
- (2011) Tadahiro Uemura et al. TRANSPLANT INTERNATIONAL
- Early Withdrawal of Calcineurin Inhibitors and Everolimus Monotherapy in de novo Liver Transplant Recipients Preserves Renal Function
- (2010) M. Masetti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Anti-thymocyte Globulin for the Treatment of Acute Cellular Rejection Following Liver Transplantation
- (2010) Timothy M. Schmitt et al. DIGESTIVE DISEASES AND SCIENCES
- Patterns of Injury in Mycophenolate Mofetil–Related Colitis
- (2010) A.I. Al-Absi et al. TRANSPLANTATION PROCEEDINGS
- Alemtuzumab and liver transplantation: a review
- (2009) Shawn Dhesi et al. Current Opinion in Organ Transplantation
- mTOR inhibitors for hepatocellular cancer: a forward-moving target
- (2009) Gerhard Treiber Expert Review of Anticancer Therapy
- Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma
- (2009) Christian Toso et al. HEPATOLOGY
- Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: A prospective, randomized, multicenter trial
- (2009) Paolo De Simone et al. LIVER TRANSPLANTATION
- Unique Aspects of Rejection and Tolerance in Liver Transplantation
- (2009) Stuart Knechtle et al. SEMINARS IN LIVER DISEASE
- Early plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantation
- (2009) Nassim Kamar et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Overview of immunosuppression in liver transplantation
- (2009) Anjana A Pillai et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Mycophenolate Mofetil-related Gastrointestinal Mucosal Injury: Variable Injury Patterns, Including Graft-versus-Host Disease-like Changes
- (2008) Jeremy R. Parfitt et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Mammalian Target of Rapamycin Inhibitor Dyslipidemia in Kidney Transplant Recipients
- (2008) B. L. Kasiske et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Delayed Introduction of Reduced-Dose Tacrolimus, and Renal Function in Liver Transplantation: The ‘ReSpECT' Study
- (2008) J. M. Neuberger et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Tacrolimus Monotherapy in Liver Transplantation
- (2008) Jan Lerut et al. ANNALS OF SURGERY
- Immunosuppression for liver transplantation
- (2008) E K Geissler et al. GUT
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started